ストックスクリーナーアプリを入手
16.55
1.04%
0.17
プレマーケット:
16.50
-0.05
-0.30%
Adma Biologics Inc (ADMA) 最新ニュース
Legato Capital Management LLC Has $433,000 Holdings in ADMA Biologics Inc $ADMA - MarketBeat
American Century Companies Inc. Purchases 84,934 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Is ADMA Biologics (ADMA) Attractive After Recent Share Price Swings And DCF Upside? - simplywall.st
ADMA Biologics (NASDAQ:ADMA) Upgraded at Zacks Research - MarketBeat
ADMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ADMA Biologics (ADMA) Q4 2025 Earnings Transcript - AOL.com
Adma Biologics (ADMA) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It? - Finviz
Royce & Associates LP Acquires 292,819 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc $ADMA Shares Bought by Rafferty Asset Management LLC - MarketBeat
ADMA Biologics (ADMA) CEO withholds 54,858 shares to cover RSU tax obligations - Stock Titan
ADMA Biologics (ADMA) Announces $200M Capital Return Plan for 20 - GuruFocus
ADMA Biologics Announces $200 Mln Capital Return Plan - Nasdaq
ADMA Biologics Launches Major 2026 Capital Return Plan - TipRanks
ADMA Biologics (NASDAQ: ADMA) recently announced a $125 million accelerated share repurchase agreement with JPMorgan. - Bitget
ADMA Biologics launches $125M accelerated share repurchase as part of ~$200M 2026 buyback plan - TradingView
ADMA Biologics (ADMA) launches $125M accelerated buyback in $200M 2026 plan - Stock Titan
ADMA Biologics commits $125M into rapid buyback, targets $200M in 2026 - Stock Titan
(ADMA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ADMA Biologics (ADMA) Margin Compression Challenges Bullish Growth Narratives Heading Into Earnings - Sahm
Vanguard Group Inc. Sells 388,719 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics (ADMA) Valuation After Revenue Growth Guidance Reaffirmation And CFO Transition - Sahm
ADMA Biologics (NASDAQ:ADMA) Upgraded at Wall Street Zen - MarketBeat
ADMA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
ADMA Biologics (NASDAQ: ADMA) CFO details stock and option holdings - Stock Titan
A Look At ADMA Biologics (ADMA) Valuation After Record Results Guidance And CFO Appointment - Yahoo Finance
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance - Finviz
Westfield Capital Management Co. LP Takes $74.87 Million Position in ADMA Biologics Inc $ADMA - MarketBeat
New ADMA Biologics CFO Takes Helm As Valuation Gap Draws Focus - Yahoo Finance
ADMA Biologics CFO Shift Puts Spotlight On Margins And Valuation - Sahm
ADMA Biologics Inc earnings beat by $0.01, revenue fell short of estimates - Investing.com UK
Decoding ADMA Biologics Inc (ADMA): A Strategic SWOT Insight - GuruFocus
ADMA Biologics Inc (ADMA) Q4 2025 Earnings Call Highlights: Stro - GuruFocus
ADMA Biologics (ADMA) Reports Strong 2025 Results and Positive O - GuruFocus
ADMA Biologics Reports Strong Q4 2025 Earnings and Positive Outlook - Intellectia AI
ADMA Biologics Q4 2025 Earnings Call Transcript - MarketBeat
ADMA forecasts $635M revenue for 2026 as ASCENIV drives margin expansion and new supply deals extend growth runway - MSN
ADMA Biologics Q4 Earnings Call Highlights - MarketBeat
ADMA Biologics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
ADMA Biologics Says Brad Tade Is Retiring As Chief Financial Officer - TradingView
Earnings call transcript: ADMA Biologics reports strong Q4 2025 growth - Investing.com
ADMA Biologics (NASDAQ:ADMA) Issues Quarterly Earnings Results - MarketBeat
ADMA BIOLOGICS, INC. SEC 10-K Report - TradingView
ADMA Biologics (NASDAQ: ADMA) maps yield gains, plasma shifts and SG-001 pipeline - Stock Titan
Tranche Update on ADMA Biologics, Inc.'s Equity Buyback Plan announced on May 7, 2025. - marketscreener.com
ADMA Biologics Q4 Earnings Fall, Revenue Rise - marketscreener.com
ADMA Biologics Inc (ADMA) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
Earnings Flash (ADMA) ADMA Biologics Posts Q4 EPS $0.20, vs. FactSet Est of $0.19 - marketscreener.com
(ADMA) ADMA Biologics Expects 2026 Revenue to Exceed $635M, vs. FactSet Est of $633.8M - marketscreener.com
Adma Biologics: Fourth Quarter Financial Overview - Bitget
ADMA Biologics Announces CFO Transition and Leadership Change - TipRanks
Adma Biologics: Q4 Earnings Snapshot - marketscreener.com
ADMA Biologics CFO Brad Tade retires; Terry Kohler promoted to CFO - TradingView
ADMA Biologics (ADMA) delivers record 2025 growth and names new CFO - Stock Titan
ADMA Biologics targets $1.1B sales by 2029 after 20% 2025 jump - Stock Titan
ADMA Biologics earnings up next: Can momentum match lofty targets? - Investing.com
ADMA Biologics earnings up next: Can momentum match lofty targets? By Investing.com - Investing.com Canada
Will ADMA’s (ADMA) Q4 2025 Earnings and Profit Focus Quiet Skeptics of Its Business Model? - Sahm
Aug Outlook: Is ADMA Biologics Inc attractive for institutional investorsGap Down & Weekly High Return Stock Opportunities - baoquankhu1.vn
Aug Outlook: Whats the beta of ADMA Biologics Inc stockMarket Activity Recap & Short-Term Swing Trade Alerts - baoquankhu1.vn
0.11%
6.00%
大文字化:
|
ボリューム (24 時間):